XML 63 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Research and License Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Research and License Agreements            
Revenue from collaboration and license agreements       $ 75,000 $ 1,159,767 $ 10,162,935
Apollomics, Inc.            
Research and License Agreements            
Revenue from sale of clinical supplies       $ 0 $ 1,100,000  
Up-front payment received     $ 9,000,000.0      
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0 $ 1,000,000.0        
Apollomics, Inc. | Maximum            
Research and License Agreements            
Milestones based on achievement of certain clinical and regulatory events     75,000,000.0      
Milestone payment upon achievement of specified net sales thresholds for all licensed products     $ 105,000,000.0      
Tiered percentage of annual net sales     15.00%